JPY 1514.0
(-0.26%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 21.36 Billion | 19.31 Billion | 17.03 Billion | 17.79 Billion | 18.07 Billion |
Cost of Revenue | 8.28 Billion | 8.17 Billion | 7.06 Billion | 7.21 Billion | 7.39 Billion |
Gross Profit | 13.07 Billion | 11.13 Billion | 9.96 Billion | 10.57 Billion | 10.68 Billion |
Operating Expenses | 11.36 Billion | 10.46 Billion | 9.73 Billion | 9.97 Billion | 10.61 Billion |
Selling, General and Administrative Expenses | - | 10.05 Billion | 9.42 Billion | 9.65 Billion | 10.26 Billion |
Research and Development Expenses | - | - | - | - | - |
Other Expenses | 11.36 Billion | 153.56 Million | 1.45 Billion | 262.9 Million | 46.74 Million |
Cost and Expenses | 19.65 Billion | 18.64 Billion | 16.8 Billion | 17.19 Billion | 18 Billion |
Operating Income | 1.7 Billion | 669.38 Million | 227.63 Million | 603.1 Million | 71.65 Million |
Interest Expense | 421 Thousand | 932 Thousand | 1.11 Million | 4.09 Million | 1.22 Million |
Income Tax Expense | 467.63 Million | 211.63 Million | 583.81 Million | 232.33 Million | -36.24 Million |
Earnings before Tax | 1.54 Billion | 769.8 Million | 1.64 Billion | 611.29 Million | -129.72 Million |
Net Income | 1.07 Billion | 558.17 Million | 1.05 Billion | 378.96 Million | -93.47 Million |
Earnings Per Share Basic | 78.34 | 40.75 | 77.16 | 27.66 | -6.83 |
Earnings Per Share Diluted | 78.08 | 40.73 | 77.14 | 27.66 | -6.83 |
Weighted Average Shares Outstanding | 13.7 Million | 13.69 Million | 13.69 Million | 13.69 Million | 13.68 Million |
Weighted Average Shares Outstanding (Diluted) | 13.74 Million | 13.7 Million | 13.7 Million | 13.69 Million | 13.68 Million |
Gross Margin | 0.61 | 0.58 | 0.59 | 0.59 | 0.59 |
EBIT Margin | 0.10 | 0.06 | 0.12 | 0.06 | 0.02 |
Profit Margin | 0.05 | 0.03 | 0.06 | 0.02 | -0.01 |
EBITDA | 2.17 Billion | 1.15 Billion | 1.92 Billion | 895.28 Million | 174.95 Million |
Earnings Before Tax Margin | 0.08 | 0.03 | 0.01 | 0.03 | 0.00 |
Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Revenue | 5.57 Billion | 21.36 Billion | 5.55 Billion | 5.63 Billion | 5 Billion | 5.16 Billion |
Cost of Revenue | 2.13 Billion | 8.28 Billion | 2.11 Billion | 2.22 Billion | 1.95 Billion | 1.98 Billion |
Gross Profit | 3.44 Billion | 13.07 Billion | 3.43 Billion | 3.41 Billion | 3.04 Billion | 3.18 Billion |
Operating Expenses | 2.95 Billion | 11.36 Billion | 3.15 Billion | 2.89 Billion | 2.72 Billion | 2.59 Billion |
Selling, General and Administrative Expenses | 2.95 Billion | - | 3.15 Billion | 2.89 Billion | 2.72 Billion | 2.59 Billion |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 1 Million | -39.96 Million | 9.37 Million | 4.12 Million | 9.23 Million | 1.93 Million |
Cost and Expenses | 5.08 Billion | 19.65 Billion | 5.27 Billion | 5.11 Billion | 4.68 Billion | 4.58 Billion |
Operating Income | 488 Million | 1.7 Billion | 279.57 Million | 519.14 Million | 324.7 Million | 585.59 Million |
Interest Expense | - | 421 Thousand | 193 Thousand | 88 Thousand | 40 Thousand | 100 Thousand |
Income Tax Expense | 105 Million | 467.63 Million | -4.45 Million | 131.9 Million | 121.83 Million | 218.34 Million |
Earnings before Tax | 282 Million | 1.54 Billion | 274.55 Million | 353.89 Million | 326.96 Million | 585.79 Million |
Net Income | 177 Million | 1.07 Billion | 279.01 Million | 221.99 Million | 205.12 Million | 367.44 Million |
Earnings Per Share Basic | 12.90 | - | 20.33 | 26.82 | 14.97 | 26.82 |
Earnings Per Share Diluted | 12.89 | - | 20.20 | 26.80 | 14.95 | 26.80 |
Weighted Average Shares Outstanding | 13.73 Million | 13.7 Million | 13.72 Million | 13.69 Million | 13.7 Million | 13.69 Million |
Weighted Average Shares Outstanding (Diluted) | 13.73 Million | 13.75 Million | 13.81 Million | 13.71 Million | 13.7 Million | 13.71 Million |
Gross Margin | 0.62 | 0.61 | 0.62 | 0.61 | 0.61 | 0.62 |
EBIT Margin | 0.11 | - | 0.07 | 0.09 | 0.07 | 0.11 |
Profit Margin | 0.03 | 0.05 | 0.05 | 0.04 | 0.04 | 0.07 |
EBITDA | 605.25 Million | - | 414.15 Million | 523.5 Million | 334.15 Million | 587.75 Million |
Earnings Before Tax Margin | 0.09 | 0.08 | 0.05 | 0.09 | 0.06 | 0.11 |
9385
8030
8060
4320
PRIMESECU
AUROPHARMA